Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Optic Neuropathy, Ischemic | 10 | 2022 | 19 | 5.420 |
Why?
|
Retinal Vessels | 14 | 2018 | 58 | 4.400 |
Why?
|
Retinal Diseases | 11 | 2023 | 90 | 3.980 |
Why?
|
Retina | 13 | 2021 | 213 | 3.980 |
Why?
|
Ischemia | 13 | 2024 | 243 | 3.780 |
Why?
|
Spinal Fusion | 8 | 2020 | 85 | 3.280 |
Why?
|
Ischemic Preconditioning | 10 | 2016 | 37 | 3.040 |
Why?
|
Extracellular Vesicles | 4 | 2023 | 42 | 2.980 |
Why?
|
Reperfusion Injury | 12 | 2024 | 131 | 2.950 |
Why?
|
Ischemic Postconditioning | 5 | 2020 | 10 | 2.550 |
Why?
|
Postoperative Complications | 11 | 2020 | 2207 | 2.350 |
Why?
|
Cardiac Surgical Procedures | 4 | 2022 | 462 | 1.810 |
Why?
|
Mesenchymal Stem Cell Transplantation | 3 | 2017 | 53 | 1.580 |
Why?
|
Bone Marrow Cells | 3 | 2017 | 253 | 1.520 |
Why?
|
Blindness | 5 | 2022 | 41 | 1.500 |
Why?
|
Electroretinography | 16 | 2018 | 76 | 1.500 |
Why?
|
Rats | 24 | 2023 | 3990 | 1.500 |
Why?
|
Intraoperative Complications | 4 | 2016 | 185 | 1.340 |
Why?
|
Culture Media, Conditioned | 3 | 2019 | 104 | 1.330 |
Why?
|
Retinal Artery Occlusion | 3 | 2018 | 12 | 1.320 |
Why?
|
Inpatients | 4 | 2020 | 297 | 1.210 |
Why?
|
Apoptosis | 12 | 2017 | 1683 | 1.100 |
Why?
|
Hypoxia | 3 | 2023 | 641 | 1.090 |
Why?
|
Disease Models, Animal | 9 | 2019 | 2232 | 0.960 |
Why?
|
Rats, Wistar | 8 | 2020 | 297 | 0.950 |
Why?
|
Neuroprotective Agents | 4 | 2019 | 94 | 0.950 |
Why?
|
Incidence | 9 | 2020 | 1577 | 0.940 |
Why?
|
Risk Factors | 15 | 2022 | 5417 | 0.940 |
Why?
|
Anesthesiology | 2 | 2019 | 157 | 0.920 |
Why?
|
Rats, Sprague-Dawley | 14 | 2019 | 1219 | 0.870 |
Why?
|
Glaucoma | 1 | 2022 | 30 | 0.860 |
Why?
|
Anesthetics | 1 | 2022 | 48 | 0.850 |
Why?
|
Spine | 4 | 2009 | 102 | 0.840 |
Why?
|
Optic Neuritis | 1 | 2021 | 10 | 0.840 |
Why?
|
Neuromyelitis Optica | 1 | 2021 | 22 | 0.820 |
Why?
|
Animals | 30 | 2024 | 26582 | 0.820 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2011 | 125 | 0.820 |
Why?
|
In Situ Nick-End Labeling | 9 | 2017 | 121 | 0.790 |
Why?
|
Head-Down Tilt | 2 | 2018 | 5 | 0.770 |
Why?
|
Beclin-1 | 1 | 2020 | 14 | 0.750 |
Why?
|
Retinal Ganglion Cells | 5 | 2024 | 66 | 0.750 |
Why?
|
Hemodilution | 2 | 2018 | 13 | 0.740 |
Why?
|
Scoliosis | 1 | 2020 | 31 | 0.740 |
Why?
|
Neurosurgical Procedures | 3 | 2010 | 213 | 0.740 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 322 | 0.730 |
Why?
|
Eye Diseases | 1 | 2019 | 53 | 0.700 |
Why?
|
Research Support as Topic | 1 | 2019 | 80 | 0.700 |
Why?
|
Ophthalmology | 1 | 2019 | 39 | 0.690 |
Why?
|
Research Personnel | 1 | 2019 | 67 | 0.690 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 3 | 0.680 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2019 | 122 | 0.680 |
Why?
|
Neurology | 1 | 2019 | 70 | 0.680 |
Why?
|
Autophagy | 2 | 2020 | 149 | 0.670 |
Why?
|
Nervous System Diseases | 1 | 2019 | 151 | 0.660 |
Why?
|
Male | 31 | 2022 | 40966 | 0.650 |
Why?
|
Hippocampus | 2 | 2021 | 442 | 0.650 |
Why?
|
Prone Position | 4 | 2009 | 56 | 0.650 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2021 | 219 | 0.640 |
Why?
|
Databases, Factual | 7 | 2018 | 814 | 0.640 |
Why?
|
Learning | 1 | 2021 | 280 | 0.640 |
Why?
|
MicroRNAs | 1 | 2023 | 534 | 0.630 |
Why?
|
Retinal Degeneration | 2 | 2017 | 28 | 0.620 |
Why?
|
Arthroplasty, Replacement | 1 | 2018 | 37 | 0.620 |
Why?
|
Nerve Block | 1 | 2018 | 51 | 0.610 |
Why?
|
Anesthetics, Local | 1 | 2018 | 76 | 0.600 |
Why?
|
Intraocular Pressure | 6 | 2011 | 54 | 0.600 |
Why?
|
Glucose | 1 | 2020 | 638 | 0.600 |
Why?
|
Eye Proteins | 1 | 2018 | 128 | 0.590 |
Why?
|
United States | 10 | 2020 | 6672 | 0.580 |
Why?
|
Anesthesia, Inhalation | 2 | 2015 | 36 | 0.560 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 295 | 0.560 |
Why?
|
Retinal Neurons | 2 | 2021 | 10 | 0.550 |
Why?
|
Sex Factors | 5 | 2020 | 1054 | 0.540 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 199 | 0.530 |
Why?
|
Corneal Injuries | 1 | 2015 | 10 | 0.530 |
Why?
|
Prostatectomy | 3 | 2015 | 471 | 0.530 |
Why?
|
Biomedical Research | 1 | 2019 | 376 | 0.530 |
Why?
|
Blotting, Western | 8 | 2014 | 782 | 0.530 |
Why?
|
Isoflurane | 1 | 2015 | 64 | 0.520 |
Why?
|
Oxygen | 1 | 2020 | 726 | 0.520 |
Why?
|
Humans | 36 | 2022 | 86644 | 0.510 |
Why?
|
Orthopedic Procedures | 2 | 2009 | 128 | 0.500 |
Why?
|
Dual Specificity Phosphatase 1 | 2 | 2011 | 17 | 0.490 |
Why?
|
Heart Diseases | 1 | 2016 | 290 | 0.480 |
Why?
|
Hysterectomy | 1 | 2015 | 146 | 0.480 |
Why?
|
Intravitreal Injections | 3 | 2021 | 67 | 0.470 |
Why?
|
Physicians | 1 | 2019 | 673 | 0.420 |
Why?
|
Neurons | 5 | 2015 | 1546 | 0.410 |
Why?
|
Vision Disorders | 2 | 2009 | 75 | 0.410 |
Why?
|
Middle Aged | 16 | 2020 | 25028 | 0.400 |
Why?
|
Erythropoietin | 2 | 2009 | 91 | 0.390 |
Why?
|
Potassium Channels | 3 | 2009 | 340 | 0.380 |
Why?
|
Anesthesia | 2 | 2010 | 164 | 0.380 |
Why?
|
Astrocytes | 2 | 2021 | 139 | 0.370 |
Why?
|
Protein Kinase C | 2 | 2008 | 270 | 0.360 |
Why?
|
Receptors, Erythropoietin | 2 | 2009 | 14 | 0.360 |
Why?
|
Fluorescent Antibody Technique, Indirect | 5 | 2010 | 68 | 0.360 |
Why?
|
Hospital Mortality | 2 | 2010 | 349 | 0.360 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2009 | 6 | 0.360 |
Why?
|
Age Factors | 4 | 2020 | 1851 | 0.350 |
Why?
|
Retrospective Studies | 7 | 2022 | 8489 | 0.350 |
Why?
|
Craniotomy | 3 | 2010 | 88 | 0.350 |
Why?
|
Surgical Equipment | 1 | 2009 | 5 | 0.350 |
Why?
|
Aged | 13 | 2018 | 18415 | 0.350 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 1920 | 0.350 |
Why?
|
Odds Ratio | 3 | 2018 | 678 | 0.340 |
Why?
|
Perioperative Care | 2 | 2022 | 161 | 0.340 |
Why?
|
Neurosurgery | 1 | 2010 | 84 | 0.330 |
Why?
|
Diazoxide | 4 | 2009 | 19 | 0.330 |
Why?
|
Female | 16 | 2020 | 44533 | 0.320 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 120 | 0.320 |
Why?
|
Spinal Cord | 1 | 2009 | 249 | 0.320 |
Why?
|
Operating Rooms | 1 | 2009 | 126 | 0.310 |
Why?
|
Eye Protective Devices | 1 | 2007 | 3 | 0.310 |
Why?
|
Time Factors | 5 | 2018 | 5210 | 0.290 |
Why?
|
Risk Assessment | 3 | 2022 | 2261 | 0.270 |
Why?
|
Tonometry, Ocular | 2 | 2018 | 10 | 0.260 |
Why?
|
Embolism, Air | 1 | 2004 | 23 | 0.250 |
Why?
|
Multivariate Analysis | 2 | 2018 | 999 | 0.250 |
Why?
|
Phosphorylation | 4 | 2010 | 1106 | 0.240 |
Why?
|
Comorbidity | 3 | 2016 | 943 | 0.240 |
Why?
|
Cells, Cultured | 3 | 2016 | 2818 | 0.230 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 171 | 0.230 |
Why?
|
Anti-Inflammatory Agents | 2 | 2024 | 339 | 0.230 |
Why?
|
RNA, Small Interfering | 3 | 2011 | 547 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 222 | 0.220 |
Why?
|
Eyelids | 2 | 2013 | 23 | 0.220 |
Why?
|
Child | 4 | 2021 | 6927 | 0.210 |
Why?
|
Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 9 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 189 | 0.200 |
Why?
|
Adolescent | 4 | 2020 | 8981 | 0.200 |
Why?
|
Fluorescence | 1 | 2021 | 102 | 0.200 |
Why?
|
Registries | 2 | 2019 | 702 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2021 | 165 | 0.190 |
Why?
|
Logistic Models | 2 | 2018 | 1186 | 0.190 |
Why?
|
Microglia | 1 | 2021 | 102 | 0.190 |
Why?
|
Rhabdomyolysis | 1 | 2020 | 28 | 0.180 |
Why?
|
Endothelial Cells | 1 | 2023 | 428 | 0.180 |
Why?
|
Financial Management | 1 | 2019 | 21 | 0.180 |
Why?
|
International Classification of Diseases | 1 | 2020 | 69 | 0.180 |
Why?
|
Cardiopulmonary Bypass | 1 | 2020 | 148 | 0.180 |
Why?
|
Datasets as Topic | 1 | 2019 | 71 | 0.180 |
Why?
|
Principal Component Analysis | 1 | 2020 | 155 | 0.180 |
Why?
|
Lysosomes | 1 | 2020 | 104 | 0.180 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 115 | 0.180 |
Why?
|
Robotics | 2 | 2015 | 267 | 0.170 |
Why?
|
Cell Death | 1 | 2020 | 256 | 0.170 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 63 | 0.170 |
Why?
|
Aged, 80 and over | 4 | 2018 | 6509 | 0.170 |
Why?
|
Cluster Analysis | 1 | 2020 | 369 | 0.170 |
Why?
|
Thrombocytopenia | 1 | 2020 | 183 | 0.170 |
Why?
|
Sleep Apnea Syndromes | 1 | 2020 | 103 | 0.170 |
Why?
|
Cytokines | 1 | 2023 | 776 | 0.170 |
Why?
|
RNA Interference | 2 | 2010 | 369 | 0.170 |
Why?
|
Treatment Outcome | 4 | 2015 | 7993 | 0.160 |
Why?
|
Adult | 8 | 2018 | 25648 | 0.160 |
Why?
|
Kinetics | 1 | 2021 | 1513 | 0.160 |
Why?
|
Perioperative Period | 1 | 2018 | 25 | 0.160 |
Why?
|
Cerebral Palsy | 1 | 2018 | 90 | 0.160 |
Why?
|
Models, Statistical | 2 | 2020 | 574 | 0.160 |
Why?
|
Case-Control Studies | 1 | 2022 | 1805 | 0.160 |
Why?
|
Spinal Injuries | 1 | 2017 | 22 | 0.160 |
Why?
|
Isoenzymes | 2 | 2008 | 271 | 0.150 |
Why?
|
Cell Count | 2 | 2011 | 195 | 0.150 |
Why?
|
Gait Disorders, Neurologic | 1 | 2017 | 16 | 0.150 |
Why?
|
Blood-Retinal Barrier | 1 | 2017 | 4 | 0.150 |
Why?
|
Young Adult | 4 | 2016 | 5976 | 0.150 |
Why?
|
Biocompatible Materials | 1 | 2019 | 193 | 0.150 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 364 | 0.150 |
Why?
|
Sex Distribution | 1 | 2017 | 173 | 0.150 |
Why?
|
Injections, Intraocular | 1 | 2016 | 5 | 0.140 |
Why?
|
Capillary Permeability | 1 | 2017 | 130 | 0.140 |
Why?
|
Causality | 1 | 2016 | 81 | 0.140 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 217 | 0.140 |
Why?
|
Obesity | 2 | 2016 | 963 | 0.140 |
Why?
|
Anemia | 2 | 2009 | 128 | 0.140 |
Why?
|
Locomotion | 1 | 2017 | 131 | 0.140 |
Why?
|
Facial Muscles | 2 | 2013 | 23 | 0.140 |
Why?
|
Oculomotor Muscles | 2 | 2013 | 28 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2016 | 157 | 0.130 |
Why?
|
Spinal Cord Stimulation | 1 | 2015 | 13 | 0.130 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 1673 | 0.130 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 1621 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 2 | 2009 | 589 | 0.130 |
Why?
|
Epilepsy | 1 | 2018 | 397 | 0.120 |
Why?
|
Cell Line | 1 | 2019 | 2468 | 0.120 |
Why?
|
Lumbar Vertebrae | 2 | 2007 | 148 | 0.120 |
Why?
|
Brain Ischemia | 1 | 2018 | 398 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 103 | 0.120 |
Why?
|
Cohort Studies | 1 | 2020 | 2767 | 0.110 |
Why?
|
Tendons | 1 | 2013 | 44 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 639 | 0.110 |
Why?
|
Chronic Pain | 1 | 2015 | 145 | 0.110 |
Why?
|
Cell Proliferation | 1 | 2019 | 1578 | 0.110 |
Why?
|
Blood Pressure | 2 | 2011 | 1143 | 0.110 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 480 | 0.110 |
Why?
|
Flow Cytometry | 1 | 2014 | 679 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 1384 | 0.110 |
Why?
|
Leupeptins | 1 | 2011 | 21 | 0.100 |
Why?
|
Imidazoles | 2 | 2010 | 162 | 0.100 |
Why?
|
Blood Loss, Surgical | 3 | 2009 | 112 | 0.100 |
Why?
|
Retinal Bipolar Cells | 1 | 2010 | 3 | 0.100 |
Why?
|
Cytoprotection | 1 | 2011 | 47 | 0.100 |
Why?
|
Calpain | 1 | 2011 | 111 | 0.100 |
Why?
|
Solubility | 2 | 2009 | 177 | 0.100 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2010 | 67 | 0.090 |
Why?
|
Warm Ischemia | 1 | 2010 | 28 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2011 | 270 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2010 | 83 | 0.090 |
Why?
|
Cerebral Revascularization | 1 | 2010 | 26 | 0.090 |
Why?
|
Blindness, Cortical | 1 | 2009 | 8 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 188 | 0.090 |
Why?
|
Anisomycin | 1 | 2009 | 9 | 0.090 |
Why?
|
Necrosis | 1 | 2010 | 204 | 0.090 |
Why?
|
Adenosine A1 Receptor Antagonists | 1 | 2009 | 4 | 0.090 |
Why?
|
Transfusion Reaction | 1 | 2009 | 15 | 0.090 |
Why?
|
Receptor, Adenosine A1 | 1 | 2009 | 8 | 0.090 |
Why?
|
Receptor, Adenosine A2A | 1 | 2009 | 15 | 0.090 |
Why?
|
Enzyme Activators | 1 | 2009 | 14 | 0.090 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2009 | 13 | 0.090 |
Why?
|
Recovery of Function | 1 | 2011 | 272 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2010 | 154 | 0.090 |
Why?
|
Databases as Topic | 1 | 2009 | 92 | 0.090 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2009 | 11 | 0.090 |
Why?
|
Stroke | 1 | 2018 | 965 | 0.090 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2009 | 33 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2010 | 54 | 0.090 |
Why?
|
Erythrocyte Transfusion | 1 | 2009 | 60 | 0.090 |
Why?
|
Chlorpropamide | 1 | 2008 | 3 | 0.090 |
Why?
|
Intervertebral Disc Displacement | 1 | 2009 | 24 | 0.090 |
Why?
|
Accidental Falls | 1 | 2009 | 50 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2009 | 44 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2009 | 278 | 0.080 |
Why?
|
Equipment Failure | 1 | 2009 | 119 | 0.080 |
Why?
|
Androstadienes | 1 | 2008 | 72 | 0.080 |
Why?
|
Benzopyrans | 1 | 2008 | 20 | 0.080 |
Why?
|
Acetophenones | 1 | 2008 | 27 | 0.080 |
Why?
|
Posture | 2 | 2006 | 125 | 0.080 |
Why?
|
Laparoscopy | 1 | 2015 | 754 | 0.080 |
Why?
|
Vasodilator Agents | 1 | 2008 | 152 | 0.080 |
Why?
|
Caspases | 2 | 2010 | 155 | 0.080 |
Why?
|
Pyridines | 1 | 2009 | 310 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2010 | 763 | 0.080 |
Why?
|
Head Protective Devices | 1 | 2007 | 20 | 0.070 |
Why?
|
Eye | 2 | 2005 | 111 | 0.070 |
Why?
|
Supine Position | 2 | 2006 | 30 | 0.070 |
Why?
|
Length of Stay | 1 | 2010 | 702 | 0.070 |
Why?
|
Hydroxy Acids | 1 | 2006 | 9 | 0.070 |
Why?
|
Nitroarginine | 1 | 2006 | 16 | 0.070 |
Why?
|
Decanoic Acids | 1 | 2006 | 11 | 0.070 |
Why?
|
Liver Failure, Acute | 1 | 2006 | 38 | 0.070 |
Why?
|
Potassium Channel Blockers | 1 | 2006 | 64 | 0.070 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2006 | 88 | 0.070 |
Why?
|
Prevalence | 1 | 2009 | 1239 | 0.070 |
Why?
|
Subthalamus | 1 | 2004 | 2 | 0.060 |
Why?
|
Radiography | 1 | 2007 | 813 | 0.060 |
Why?
|
Biomarkers | 1 | 2011 | 1718 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2006 | 278 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 1961 | 0.060 |
Why?
|
Regional Blood Flow | 1 | 2005 | 197 | 0.060 |
Why?
|
Hemoglobins | 1 | 2005 | 179 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2004 | 51 | 0.060 |
Why?
|
Reperfusion | 1 | 2024 | 31 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 68 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 74 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2004 | 109 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 1721 | 0.060 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 113 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2004 | 132 | 0.060 |
Why?
|
Prosthesis Implantation | 1 | 2004 | 125 | 0.060 |
Why?
|
Caspase 2 | 1 | 2002 | 9 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2002 | 47 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 46 | 0.050 |
Why?
|
Mitochondria | 1 | 2006 | 535 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 268 | 0.050 |
Why?
|
Caspase 3 | 1 | 2002 | 159 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 101 | 0.050 |
Why?
|
Heat-Shock Proteins | 1 | 2003 | 179 | 0.050 |
Why?
|
Carbon Dioxide | 1 | 2002 | 188 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2003 | 1753 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 645 | 0.040 |
Why?
|
Signal Transduction | 1 | 2009 | 3241 | 0.040 |
Why?
|
Inflammation | 1 | 2024 | 920 | 0.040 |
Why?
|
Survivors | 1 | 2018 | 226 | 0.040 |
Why?
|
Workers' Compensation | 1 | 2015 | 4 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 17 | 0.030 |
Why?
|
Pain Measurement | 1 | 2015 | 321 | 0.030 |
Why?
|
Blepharoptosis | 1 | 2013 | 11 | 0.030 |
Why?
|
Fasciotomy | 1 | 2013 | 16 | 0.030 |
Why?
|
Cadaver | 1 | 2013 | 185 | 0.030 |
Why?
|
Reoperation | 1 | 2015 | 597 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2018 | 2380 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2017 | 1801 | 0.030 |
Why?
|
Body Mass Index | 1 | 2015 | 770 | 0.030 |
Why?
|
Connective Tissue | 1 | 2011 | 23 | 0.030 |
Why?
|
Ligaments | 1 | 2011 | 32 | 0.030 |
Why?
|
Orbit | 1 | 2011 | 37 | 0.020 |
Why?
|
Smoking | 1 | 2015 | 609 | 0.020 |
Why?
|
Mice | 1 | 2024 | 11352 | 0.020 |
Why?
|
Blood Volume | 1 | 2009 | 51 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2009 | 90 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2009 | 46 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2009 | 106 | 0.020 |
Why?
|
Medicine | 1 | 2009 | 89 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2009 | 102 | 0.020 |
Why?
|
Indoles | 1 | 2010 | 318 | 0.020 |
Why?
|
Linear Models | 1 | 2009 | 421 | 0.020 |
Why?
|
Skull | 1 | 2009 | 249 | 0.020 |
Why?
|
Seizures | 1 | 2009 | 297 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2006 | 293 | 0.020 |
Why?
|
Hemodynamics | 1 | 2009 | 710 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2003 | 48 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 256 | 0.010 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2003 | 46 | 0.010 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2003 | 113 | 0.010 |
Why?
|
Liver | 1 | 2006 | 1230 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 2705 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2003 | 1981 | 0.010 |
Why?
|